MOSCOW, February 6 – RIA Novosti. The statement of Lithuanian Prime Minister Ingrida Shimonyte that the Russian authorities do not want to vaccinate Russians with Sputnik V, but use the vaccine as a “hybrid weapon,” speaks of an exorbitant level of incompetence, Elena Panina, a member of the State Duma Committee on International Affairs, told RIA Novosti.
Earlier, Shimonyte on her Twitter called the Sputnik V coronavirus vaccine a “hybrid weapon” used by the Russian authorities to spread influence in the world. At the same time, the Lithuanian prime minister said that Russian President Vladimir Putin “does not want to use the vaccine to treat the population of Russia.”
According to Panina, Western politicians are forced to admit the quality of the Russian vaccine, but at the same time “they are frantically trying to find at least some reason for innuendo.”
“Shimonyte, apparently, does not know that vaccination in the Russian Federation has already begun a long time ago … She doesn’t know, apparently, that the Russian Federation will produce“ export ”consignments mainly at foreign production sites. the creation of a combined vaccine based on Sputnik and AstraZenes. In other words, Šimonyte showed such an exorbitant level of incompetence, which is indecent even for Lithuania, “said Panina.
The parliamentarian also noted that there are positive grains in Simonyte's statement.
“Recently, some of our citizens, having learned about the side effects (of the vaccine) of Pfizer, have become wary of any vaccines in principle. Against this background, Shimonyte’s statement that they want to“ take away ”Sputnik V from the Russians will help our people overcome prejudice and encourage people to get vaccinated as soon as possible, “the deputy explained.
“Sputnik V” was registered by the Russian Ministry of Health in August 2020, it was developed by the Gamaleya Research Center for Electrochemistry. This vaccine was the first in the world to prevent COVID-19. Sputnik V is built on a well-studied and proven platform of human adenoviral vectors.
The use of the Sputnik V vaccine was previously approved in 21 countries: Russia, Belarus, Argentina, Bolivia, Serbia, Algeria, Palestine, Venezuela, Paraguay, Turkmenistan, Hungary, the United Arab Emirates, Iran, the Republic of Guinea, Tunisia, Armenia, Mexico, Nicaragua and Republika Srpska (entity of Bosnia and Herzegovina), Lebanon and Myanmar.